R1 Buys Humata Health to Automate AI Prior Authorization

HIT Consultant August 18, 2026
Read Full Article →
AI-Generated Summary

R1 has agreed to acquire Humata Health to embed AI-powered prior authorization into its Phare operating system, targeting real-time, touchless authorizations across the revenue cycle. Humata’s technology has helped physicians reach a 96% first-pass approval rate while cutting write-offs 30%, reducing rescheduled appointments 83%, and lowering manual staff touches 45%. The Humata team will join R1’s R37 innovation lab, which focuses on agentic AI. The deal — expected to close at the end of the third quarter of 2026 with undisclosed terms — signals how revenue-cycle vendors are racing to automate prior authorization, one of the costliest and most friction-heavy steps between scheduling and payment.

Why It Matters

Prior authorization is a top driver of denials, delays, and staff burden for multi-site groups. Watching how automation vendors consolidate — and the approval and write-off gains they claim — helps operators judge where AI can realistically cut revenue-cycle cost and rescheduling.

prior authorization rcm automation agentic ai revenue cycle denials management r1 rcm first-pass approval

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

Frequently asked questions

What does R1’s acquisition of Humata Health do for prior authorization?

The deal embeds Humata’s AI-powered prior authorization automation into R1’s Phare operating system, pushing toward real-time, touchless authorizations. Humata’s team joins R1’s R37 innovation lab, which develops agentic AI for the revenue cycle.

What results has Humata Health’s AI prior authorization delivered?

Humata says its technology helped physicians reach a 96% first-pass approval rate while reducing write-offs by 30%, rescheduled appointments by 83%, and manual staff touches by 45%. Financial terms of the R1 acquisition were not disclosed.

When is the R1-Humata Health deal expected to close?

R1 expects the acquisition to close at the end of the third quarter of 2026. The move is part of R1’s broader strategy to automate the revenue cycle through its Phare operating system and agentic AI.

Similar Posts